Radio-immunotherapy-induced immunogenic cancer cells as basis for induction of systemic anti-tumor immune responses–pre-clinical evidence and ongoing clinical …

A Derer, L Deloch, Y Rubner, R Fietkau, B Frey… - Frontiers in …, 2015 - frontiersin.org
Radiotherapy (RT) primarily aims to locally destroy the tumor via the induction of DNA
damage in the tumor cells. However, the so-called abscopal, namely systemic and immune …

Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy?

P Hatfield, A Merrick, K Harrington, R Vile, A Bateman… - Clinical Oncology, 2005 - Elsevier
Dendritic cells are key orchestrators of the immune system. There is considerable interest in
their use for treating cancer. Whether they initiate an effective cytotoxic response against …

Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy

AE Marciscano, A Ghasemzadeh, TR Nirschl… - Clinical Cancer …, 2018 - AACR
Purpose: In the proper context, radiotherapy can promote antitumor immunity. It is unknown
if elective nodal irradiation (ENI), a strategy that irradiates tumor-associated draining lymph …

Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy

V Shahabi, MA Postow, D Tuck… - American journal of …, 2015 - journals.lww.com
A clear contribution of the immune system to eradication of tumors has been supported by
recent developments in the field of immunotherapy. Durable clinical responses obtained …

Tumour immunogenicity, antigen presentation, and immunological barriers in cancer immunotherapy

D Escors - New journal of science, 2014 - Wiley Online Library
Since the beginning of the 20th century, scientists have tried to stimulate the antitumour
activities of the immune system to fight against cancer. However, the scientific effort devoted …

Limited capability of regional lymph nodes to eradicate metastatic cancer cells

H Nagata, T Arai, Y Soejima, H Suzuki, H Ishii, T Hibi - Cancer research, 2004 - AACR
The capacity of lymph nodes to eradicate cancer is a controversial issue. The purpose of this
study was to determine the interplay between tumor growth and host resistance at early …

Tertiary lymphoid structures as mediators of immunotherapy response

RG Vaghjiani, JJ Skitzki - Cancers, 2022 - mdpi.com
Simple Summary Tertiary lymphoid structures (TLS) are anatomic entities that are similar to,
but distinct from, secondary lymphoid structures (eg, lymph nodes) that allow for a host's own …

Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?

F Zito Marino, PA Ascierto, G Rossi… - Expert opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: Tumor-infiltrating lymphocytes (TILs) are frequently observed in
several tumors, reflecting the dynamic process of '“cancer immunoediting”'. Prognostic and …

Combining radiotherapy and immunotherapy: a revived partnership

S Demaria, N Bhardwaj, WH McBride… - International Journal of …, 2005 - Elsevier
Ionizing radiation therapy (RT) is an important local modality for the treatment of cancer. The
current rationale for its use is based largely on the ability of RT to kill the cancer cells by a …

The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership

E Chajon, J Castelli, H Marsiglia… - Critical reviews in …, 2017 - Elsevier
Radiotherapy (RT) is one of the main components in the treatment of cancer. The better
understanding of the immune mechanisms associated with tumor establishment and how RT …